RATIOS
Strides Pharma Science Ltd.
BSE
Jul 10
870.10
-2.50 ( -0.29%)
Volume
11103
Prev. Close
872.60
Open Price
877.55
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 10
870.25
-2.45 ( -0.28%)
Volume
387734
Prev. Close
872.70
Open Price
875.30
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Ratio Analysis
for the last 5 years.
ISIN No
|
INE939A01011
|
Market Cap. ( ₹ in Cr. )
|
8020.46
|
P/BV
|
3.53
|
Book Value ( ₹ )
|
246.48
|
BSE Code
|
532531
|
52 Week High/Low ( ₹ )
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
2.23
|
NSE Code
|
STAREQ
|
Book Closure
|
09/09/2024
|
EPS ( ₹ )
|
389.90
|
Div Yield (%)
|
0.46
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 313.68 | 7.20 | 0.52 | 20.08 | 8.73 |
Diluted EPS (Rs.) | 313.65 | 7.19 | 0.52 | 20.07 | 8.72 |
Cash EPS (Rs.) | 322.34 | 16.34 | 10.89 | 31.69 | 19.80 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 346.42 | 387.50 | 382.61 | 379.36 | 362.18 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 346.42 | 387.50 | 382.61 | 379.36 | 362.18 |
Dividend / Share (Rs.) | 4.00 | 2.50 | 0.00 | 0.00 | 2.50 |
Revenue From Operations / Share (Rs.) | 232.13 | 234.30 | 205.36 | 220.40 | 207.13 |
PBDIT / Share (Rs.) | 33.49 | 35.65 | 20.21 | 22.29 | 30.81 |
PBIT / Share (Rs.) | 24.31 | 26.43 | 9.85 | 10.66 | 19.73 |
PBT / Share (Rs.) | 8.47 | 7.58 | -7.17 | 2.40 | 12.45 |
Net Profit / Share (Rs.) | 313.16 | 7.13 | 0.51 | 20.07 | 8.72 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 14.42 | 15.21 | 9.84 | 10.11 | 14.87 |
PBIT Margin (%) | 10.47 | 11.28 | 4.79 | 4.83 | 9.52 |
PBT Margin (%) | 3.64 | 3.23 | -3.49 | 1.08 | 6.00 |
Net Profit Margin (%) | 134.90 | 3.04 | 0.25 | 9.10 | 4.21 |
Return on Networth / Equity (%) | 90.39 | 1.83 | 0.13 | 5.28 | 2.40 |
Return on Capital Employeed (%) | 6.58 | 6.32 | 2.32 | 2.66 | 4.87 |
Return On Assets (%) | 57.36 | 1.12 | 0.08 | 3.31 | 1.49 |
Long Term Debt / Equity (X) | 0.03 | 0.05 | 0.08 | 0.03 | 0.04 |
Total Debt / Equity (X) | 0.36 | 0.44 | 0.39 | 0.36 | 0.25 |
Asset Turnover Ratio (%) | 0.39 | 0.37 | 0.33 | 0.37 | 0.37 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.32 | 1.21 | 1.18 | 1.07 | 1.10 |
Quick Ratio (X) | 1.05 | 0.97 | 0.91 | 0.79 | 0.66 |
Inventory Turnover Ratio (X) | 2.32 | 2.23 | 2.03 | 1.56 | 1.85 |
Dividend Payout Ratio (NP) (%) | 0.00 | 20.68 | 0.00 | 0.00 | 22.89 |
Dividend Payout Ratio (CP) (%) | 0.00 | 9.02 | 0.00 | 0.00 | 10.08 |
Earning Retention Ratio (%) | 0.00 | 79.32 | 0.00 | 0.00 | 77.11 |
Cash Earning Retention Ratio (%) | 0.00 | 90.98 | 0.00 | 0.00 | 89.92 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 2.12 | 1.95 | 1.32 | 2.70 | 4.23 |
Interest Coverage Ratio (Post Tax) (%) | 1.41 | 1.42 | 1.14 | 3.43 | 2.20 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 7291.46 | 8674.44 | 3847.64 | 4341.86 | 8341.56 |
EV / Net Operating Revenue (X) | 3.41 | 4.03 | 2.07 | 2.19 | 4.49 |
EV / EBITDA (X) | 23.63 | 26.48 | 21.08 | 21.70 | 30.19 |
MarketCap / Net Operating Revenue (X) | 2.88 | 3.34 | 1.39 | 1.57 | 4.08 |
Retention Ratios (%) | 0.00 | 79.31 | 0.00 | 0.00 | 77.10 |
Price / BV (X) | 1.93 | 2.02 | 0.74 | 0.91 | 2.33 |
Price / Net Operating Revenue (X) | 2.88 | 3.34 | 1.39 | 1.57 | 4.08 |
EarningsYield | 0.46 | 0.01 | 0.00 | 0.05 | 0.01 |